Translational Biomarker Research at Providence Health Care
December 14, 2016
left to right: Broek Bosma (Chief Development Officer, St. Paul's Hospital Foundation), Marcia MacDonald (Director of Research Programs, Genome BC), Dr. Mari DeMarco (PHC Clinical Chemist), Dr. Don Sin (PHC Respiratory Medicine Division Head)
On December 12, the DeMarco lab, in partnership with the Department of Pathology and Laboratory Medicine at Providence Health Care, unveiled a new SCIEX 5500 research mass spectrometer located in the Clinical Chemistry Laboratory at St. Paul’s Hospital. The new equipment will enable the development of diagnostic tests from biofluids such as blood. This unique infrastructure represents a critical development in the ability of the team to translate their research findings directly into patient care.
This initiative is supported by a $7 million research grant, spearheaded by St. Paul’s Hospital respirologist Dr. Don Sin, to investigate blood-based biomarkers for COPD. The night included a celebration of the various funding partners that came together to make this translational research infrastructure a reality, including: Genome Canada, Genome BC, the Canadian Institutes of Health Research and the St. Paul’s Hospital Foundation.
For more information on this translation research activity, please visit: https://sites.google.com/site/chempathbio/.